Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDR | P35968 | 2/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 4/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 3/20 | 0.39 |
| ▸ | HTR2B | P41595 | 3/20 | 0.39 |
| ▸ | HTR7 | P34969 | 2/20 | 0.39 |
| ▸ | HTR6 | P50406 | 2/20 | 0.39 |
| ▸ | HTR3A | P46098 | 1/20 | 0.39 |
| ▸ | HTR1D | P28221 | 1/20 | 0.38 |
| ▸ | HTR1E | P28566 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28999660 | 0.98 | HTR2C (0.43) | KDRSIGMAR1HTR2CLMNARECQL | |
| SCHEMBL7763318 | 0.83 | LMNA (0.36) | KDRLMNANPC1RAB9AMEN1 | |
| SCHEMBL3325615 | 0.79 | QDPR (0.41) | LMNARECQLNPC1RAB9APOLB | |
| SCHEMBL6771534 | 0.79 | HTR2A (0.38) | HTR2CLMNAHTR2AHTR2BHTR7 | |
| SCHEMBL6768059 | 0.79 | KDR (0.43) | KDRHTR2CLMNAHTR2AHTR2B | |
| SCHEMBL4627244 | 0.79 | HTR2C (0.41) | HTR2CNPC1RAB9APOLBMEN1 | |
| SCHEMBL972816 | 0.78 | SMN1; SMN2 (0.52) | KDRSIGMAR1HTR2CLMNAHTR7 | |
| SCHEMBL17838640 | 0.75 | SMN1; SMN2 (0.32) | SMN1; SMN2 | |
| SCHEMBL9009115 | 0.71 | PTGS2 (0.50) | — | |
| SCHEMBL10964893 | 0.71 | DRD1 (0.41) | LMNANPC1RAB9APOLBMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117164272-A | Concrete brightening agent and preparation method thereof | 云南森博混凝土外加剂有限公司 | 2023-12-05 | — | — | CN | claimed |
| CN-117164305-A | Mirror concrete and preparation method thereof | 云南森博混凝土外加剂有限公司 | 2023-12-05 | — | — | CN | claimed |
| US-11561083-B2 | Secondary battery and apparatus and method for measuring dimension of secondary battery | LG ENERGY SOLUTION, LTD. (KR) | 2023-01-24 | — | — | US | claimed |
| US-20090129053-A1 | LIGHT-ENHANCED ELEMENT | LUMINOSO PHOTOELECTRIC TECHNOLOGY CO. (TW) | 2009-05-21 | — | — | US | claimed |
| US-20070159062-A1 | Light-enhanced element | LUMINOSO PHOTOELECTRIC TECHNOLOGY CO. | 2007-07-12 | — | — | US | claimed |
| EP-4745232-A2 | PROTEASE VARIANTS WITH IMPROVED PERFORMANCE | Henkel AG & Co. KGaA (DE) | 2026-05-20 | — | — | EP | disclosed |
| US-20260132396-A1 | PERFORMANCE-ENHANCED PROTEASE VARIANTS | HENKEL AG & CO KGAA (DE) | 2026-05-14 | — | — | US | disclosed |
| EP-4143289-B1 | HIGHLY ALKALINE TEXTILE WASHING AGENT COMPRISING PROTEASE | HENKEL AG & CO KGAA (DE) | 2026-05-06 | — | — | EP | disclosed |
| EP-4728036-A1 | PEPTIDES WITH DIRT-RELEASING EFFECT FOR DETERGENTS AND CLEANING AGENTS | Henkel AG & Co. KGaA (DE) | 2026-04-22 | — | — | EP | disclosed |
| US-12492360-B2 | Highly alkaline textile washing agent comprising protease | HENKEL AG & CO. KGAA (DE) | 2025-12-09 | — | — | US | disclosed |
| EP-4649127-A1 | ENZYME-CONTAINING DETERGENTS AND CLEANING AGENTS | Henkel AG & Co. KGaA (DE) | 2025-11-19 | — | — | EP | disclosed |
| US-20250346835-A1 | DETERGENT AND CLEANING AGENT WITH IMPROVED ENZYME STABILITY | HENKEL AG & CO KGAA (DE) | 2025-11-13 | — | — | US | disclosed |
| US-20070159062-A1 | Light-enhanced element | LUMINOSO PHOTOELECTRIC TECHNOLOGY CO. | 2007-07-12 | — | — | US | disclosed |
| US-20070159062-A1 | Light-enhanced element | LUMINOSO PHOTOELECTRIC TECHNOLOGY CO. | 2007-07-12 | — | — | US | disclosed |
| WO-2007019933-A1 | 1-ACYLDIHYDROPYRAZOL DERIVATIVES | MERCK PATENT GMBH (DE) | 2007-02-22 | — | — | WO | disclosed |
| US-6831083-B2 | For therapy and prophylaxis of cerebral ischemia (cerebral infarct and brain edema), sequela of cerebral ischemia, cephalotrauma, glaucoma, retinopathy, epilepsy and amyotrophic lateral sclerosis (ALS), all caused by glutamic acid toxicity | MITSUI CHEMICALS, INC. (JP) | 2004-12-14 | — | — | US | disclosed |
| US-20030149046-A1 | Pyrazoline derivative or tetrahydropyridazine derivative and medicinal use thereof | MITSUI CHEMICALS, INC. (JP) | 2003-08-07 | — | — | US | disclosed |
| EP-1270567-A1 | PYRAZOLINE DERIVATIVES OR TETRAHYDROPYRIDAZINE DERIVATIVES AND MEDICINAL USE THEREOF | Mitsui Chemicals, Inc. (JP) | 2003-01-02 | — | — | EP | disclosed |
| US-4140792-A | INSECTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1979-02-20 | — | — | US | disclosed |
| US-4140787-A | INSECTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1979-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030149046-A1 | Pyrazoline derivative or tetrahydropyridazine derivative and medicinal use thereof | SLC1A2, SLC1A1, SLC1A3 | KDR 606/4885SIGMAR1 3128/4885HTR2C 2262/4885 |
| US-20260132396-A1 | PERFORMANCE-ENHANCED PROTEASE VARIANTS | CTRL, DPEP1, MME | KDR 4005/4885SIGMAR1 3450/4885HTR2C 1929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.